Timothy Richardson

Timothy Richardson is the Founder of Monument Biosciences, where Timothy is dedicated to developing disease modifying drugs for Alzheimer's Disease and Related Dementias. With a background in Organic Chemistry and Biochemistry, Timothy has held various leadership roles in research and innovation at companies such as Eli Lilly and Indiana Biosciences Research Institute. Their extensive experience includes leading teams in the development of clinical candidates for autoimmune diseases, osteoarthritis, uterine fibroids, and other medical conditions.